METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets tough pancreatic cancer in early trial
Disease control CompletedThis study tested a new oral drug called IOA-289, alone and with standard chemotherapy, in 16 people with metastatic pancreatic cancer. The main goal was to find safe doses and understand side effects. Researchers also looked at how the drug moves in the body and any signs of tum…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated May 26, 2026 09:45 UTC
-
Immune booster shows promise in tough pancreatic cancer trial
Disease control CompletedThis study tested an experimental drug called indoximod, which aims to boost the immune system, together with standard chemotherapy for people with metastatic pancreatic cancer (cancer that has spread). The trial involved 157 adults and had two parts: first to find the safest dos…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New drug combo shows promise in tough pancreatic cancer
Disease control CompletedThis study tested a new combination of drugs (ABT-888 plus chemotherapy) in 64 people with pancreatic cancer that had spread. The goal was to see if blocking a DNA repair enzyme could make chemotherapy more effective at shrinking tumors. The approach aims to control the disease, …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Real-World chemotherapy patterns in advanced pancreatic cancer revealed
Knowledge-focused CompletedThis study observed 799 adults with advanced or metastatic pancreatic cancer in Korea to see which chemotherapy treatments doctors actually use and why. Researchers tracked treatment choices, survival times, and quality of life. The goal was to understand real-world practices, no…
Matched conditions: METASTATIC PANCREATIC CANCER
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 09:32 UTC